Association for the Advancement of Blood & Biotherapies Annual Meeting On-Demand 2022

Overview

The Association for the Advancement of Blood & Biotherapies Annual Meeting On-Demand 2022 provides comprehensive on-demand access to the latest developments and expert discussions in blood banking, transfusion medicine, and cellular therapies. This digital resource includes a broad range of presentations addressing practical and regulatory challenges, clinical advances, and innovations in blood and biotherapies.

On-demand hematology and transfusion medicine education — accessible anytime, anywhere.

Agenda

This collection features recorded presentations originally delivered during the 2022 annual meeting, covering critical topics relevant to blood banking and biotherapies professionals. It enables learners to strengthen their expertise through evidence-based discussions and real-world applications.

• A New Piece of Equipment… Now What
• Armed Services Blood Program Pioneering Collaborations to Forge Ahead Within the Military Health System Transformation
• Ask the FDA and CMS CLIA
• Ask the Standards
• Blood Safety Epidemiological Surveillance and Risk Assessment for Emerging Pathogens
• Blood Shortage Triage Team Engaging Hospital Leaders
• Cellular Therapy Service Quality System Considerations from a Standards Development and Application Perspective
• Changes in the Last Decade in Patient Blood Management Practices
• Clear the Way for X-Ray Discussing Benefits of Removing and Replacing Cesium Irradiators with X-Ray
• Convalescent Plasma Past, Present, Future
• COVID-19 Impact on Blood Availability and Transfusion Practices in Low- and Middle-Income Countries
• Cryopreservation of Cellular Therapy Products for Allogeneic Stem Cell Transplantation During COVID-19 Pandemic and Beyond
• Cutting Edge Concepts in Pathogenesis, Diagnosis, and Treatment of Warm Autoimmune Hemolytic Anemia
• DEIA in Focus Advancing Equity and Inclusivity for Sexual and Gender Diverse Donors
• Serologic and Molecular Challenges Within the Rh Blood Group System
• Do More with Less How to Apply the 80 20 Rule to Quality Assurance
• Effects of Transfusion on Bone Marrow Health and Transplant Outcomes in Sickle Cell Disease
• Ethical Considerations in Blood Supply Management During Critical Blood Shortages
• Global Regulatory Pathways for Biotherapies Spotlight on New Regulations in Gulf Cooperation Council and Latin American Countries and the European Union
• Heart Transplantation and High-Risk Cardiac Surgery Transfusion Support and Perioperative Therapies
• Hemolysis After High-Dose Intravenous Immunoglobulin An Under-Appreciated Sequelae
• How Climate Change May Change Infectious Diseases Risks in Blood Donors and What Can Blood Operators Do to Prepare for Shifting Threat Profiles
• Impact of COVID-19 Pandemic on Blood Collection and Utilization in the United States Preliminary Results from the 2021 National Blood Collection and Utilization Survey
• Innovations in Blood Storage to Prevent Red Blood Cell Damage
• Is It Time for the Death Knell of the Current US Apheresis Platelet Dose of 3.0 x 10ⁱ¹
• Keeping up with the Donor History Task Force Implementation of DHQ Version 3.0
• Leadership and Personal Development Challenges for Emerging Leaders
• Leveraging Your Data Through Replication and Warehousing to Meet Your Blood Bank and Transfusion Service Needs
• Low-Yield Platelets An Effective Solution to Our Platelet Shortage
• Lowering the Dose of Platelets Is the Timing Right The North American Perspective
• LVDS Is It Worth It
• Managing the Apheresis Center How Do We Produce Enough Products for the Ever-Increasing Demand
• New Frontiers for Unmanipulated Cord Blood as Well as Its Derivatives
• Oral Abstract Session Components
• Oral Abstract Session Genetic Testing and Product Quality
• Oral Abstract Session Infectious Disease
• Oral Abstract Session PBM, Hemovigilance, Education
• Oral Abstract Session Platelets and Novel Therapeutics
• Oral Abstract Session RBC Immunology Mouse Models
• Plenary Abstract Session
• Transfusion Strategies for Intracerebral Hemorrhage Evidence, Guidelines, and Novel Approaches
• Under-Recognized Complications of Transfusion
• What If the Next Pandemic Is Transmissible by Transfusion Strategies for Protecting the Blood Supply
• Who Is Transfusing Blood in Your Neighborhood Trends in Out-of-Hospital Transfusions

Speakers

This on-demand meeting features a diverse range of experts presenting on multiple aspects of blood and biotherapies. The recorded sessions enable access to authoritative insights from leaders and specialists in transfusion medicine, blood banking, cellular therapies, regulatory affairs, and clinical research.

Target Audience

This course is designed for healthcare professionals involved in transfusion medicine, hematology, blood banking, cellular therapy, and related fields. It is relevant for clinicians, laboratory staff, quality assurance personnel, regulatory specialists, and healthcare administrators seeking to update their knowledge and skills in blood and biotherapies.

Why This Topic Matters

The Association for the Advancement of Blood & Biotherapies Annual Meeting On-Demand 2022 addresses crucial advances and challenges within hematology and transfusion medicine. Staying informed through MedHub Central supports professional competence and fosters evidence-based practices vital to patient safety and effective blood product management.

This comprehensive resource enriches understanding of evolving standards, emerging pathogens, and innovations in blood therapy—key concerns for healthcare providers dedicated to optimizing transfusion outcomes and advancing biotherapy applications.